InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors

Launched by MAYO CLINIC · Nov 21, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring how the InBody Band 3 fitness tracker can help improve the health and quality of life for Black men who have survived prostate cancer. The researchers want to see if using this fitness tracker can encourage more physical activity, improve body composition (which means the amount of fat versus muscle in the body), and overall enhance well-being. Since Black men are more likely to face advanced stages of prostate cancer, understanding how to support their health is really important.

To participate, you must be at least 18 years old, identify as Black, and have been diagnosed with prostate cancer at any stage. You'll need to be able to use a smartphone and check your email regularly for study updates. If you join, you'll wear the fitness tracker for six weeks and share your activity data with the study team. This trial is currently recruiting participants, and it aims to provide valuable insights into how using a fitness tracker can support the health of Black prostate cancer survivors. If you're interested in improving your physical activity and quality of life, this could be a great opportunity for you.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Able to read/speak English and are able to communicate by phone
• • 18 years of age or older
• • Self-identify as Black
• • Have been diagnosed with stage I-IV prostate cancer
• • Have an active email address and are able to regularly check emails for electronic surveys
• • Own and are willing to use a personal smartphone with regular/reliable access to the internet to sync regularly with a fitness tracker
• • Are willing to wear and use a smart fitness tracker for 6 weeks and allow sharing of their fitness data with the study team
• • Are not currently undergoing adjunct cancer therapy (e.g. chemotherapy, radiation) during the 6 weeks of study participation, except oral tyrosine kinase inhibitor or hormonal therapies; and
• • Are an existing Mayo patient
• • Self-report that they would like to improve their physical activity during initial study coordinator contact
• Exclusion Criteria:
• • Live outside of the United States (U.S)
• • Have an implanted medical device (e.g., pacemaker, etc.) or a life-sustaining device (e.g., patient monitoring device)
• • Have a self-reported history of a psychiatric disorder(s) or moderate to severe cognitive impairment precluding participation in the study intervention or preventing the ability to provide independent informed consent
• • Are on prolonged bed rest (i.e., more than half of the waking day in bed) by self-report
• • Currently have any lower extremity injury that impedes them from engaging in walking for one block
• • Are unable to walk for at least one block without a walking aide by self-report; or
• • Regularly use a wheelchair for mobility by self-report